LYRM03, CAS [[1820750-36-4]]

Produktübersicht

• Artikelname: LYRM03, CAS [[1820750-36-4]]
• Artikelnummer: TGM-T70145
• Hersteller Artikelnummer: T70145
• Alternativnummer: TGM-T70145-25MG,TGM-T70145-50MG,TGM-T70145-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

LYRM03 is an aminopeptidase inhibitor. LYRM03 is also an ubenimex derivative. LYRM03 attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway. LYRM03 effectively attenuates LPS-induced ALI by inhibiting the expression of pro-inflammatory mediators and Myd88-dependent TLR4 signaling pathways in alveolar macrophages. LYRM03 may serve as a potential treatment for sepsis-mediated lung injuries.

Produkteigenschaften

• Molekulargewicht: 407.5
• CAS Nummer: [1820750-36-4]
• Formel: C21H33N3O5
• Target-Kategorie: Others

Bilder

T70145